Laboratorios Farmacéuticos Rovi SA (41L)
Market Open
11 Aug, 06:02
€
58. 50
+0.35
+0.6019%
€
- Market Cap
- P/E Ratio
4.37% Div Yield
180 Volume
- Eps
€ 58.15
Previous Close Want to track 41L and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
41L Earnings Reports FAQ
What is the earnings per share (EPS) for 41L?
EPS data for 41L is currently not available, as Laboratorios Farmacéuticos Rovi SA has not reported recent earnings.
What is the company's earnings growth rate?
Laboratorios Farmacéuticos Rovi SA has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Laboratorios Farmacéuticos Rovi SA has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Laboratorios Farmacéuticos Rovi SA are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 41L at this time, as Laboratorios Farmacéuticos Rovi SA has no recent EPS data to calculate it.
